Dr. Ana Ponce Kiess, MD, PhD

Dr. Kiess practices at Johns Hopkins Hospital Nelson/Harvey Building in Baltimore, Maryland.

Dr. Kiess' NPI, 1770744716, was assigned on June 23, 2008. Dr. Kiess graduated from Duke University School of Medicine in 2008. Dr. Kiess holds Maryland license D75730.

Dr. Kiess' primary practice is Johns Hopkins Hospital Nelson/Harvey Building, at 600 N Wolfe St, Baltimore, MD 21287 in Baltimore City. The practice phone is (855) 662-3017.

Dr. Kiess' primary practice is Johns Hopkins Hospital Nelson/Harvey Building in Baltimore, Maryland. Dr. Kiess is also affiliated with The Johns Hopkins Hospital. The medical group on file is Johns Hopkins University. Dmand AI also links Dr. Kiess to 2 more hospitals and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kiess practices, 3 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Kiess' primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Kiess is licensed in Maryland.

CMS data shows 2,892 Medicare services from Dr. Kiess across 16 procedure codes in 2024, for 275 Medicare patients. Medicare paid $344,630 for them.

CMS counts 275 Medicare patients who saw Dr. Kiess in 2024. The largest group is 65 to 74, with 157 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 1.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kiess' median patient age at 73, with 13% women.

In 2024, Dr. Kiess wrote 97 Medicare Part D claims for 38 patients. 80% of them were for generic drugs. CMS names the drug for 50 of them, across 4 drugs with 11 or more claims each, at $40,442 in total drug cost. In 2023, CMS named 25 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Kiess for performance year 2024, reported as part of a group. CMS lists Dr. Kiess as offering telehealth.

Dmand AI links 87 papers to Dr. Kiess, published from 2012 to 2025. 2017 was the busiest year, with 11. The most frequent topics are Head and Neck Neoplasms, Oropharyngeal Neoplasms and Radiopharmaceuticals. Dr. Kiess has published most often in Adv Radiat Oncol. Dr. Kiess' most frequent co-authors are Carole Fakhry, MD, Christine G. Gourin, MD and David W. Eisele, MD.

Dmand AI links Dr. Kiess to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Deglutition Disorders, Nasopharyngeal Carcinoma and Neoplasms, Squamous Cell.

CMS Open Payments shows 5 general payments to Dr. Kiess from 4 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Baxter Healthcare paid the most, $125. It also lists 3 research payments totaling $4,739 in 2025.

Dr. Kiess graduated from Duke University School of Medicine in 2008.